Bio-IT World September 22, 2021
Allison Proffitt

Josh Denny, CEO of the All of Us research program, gave an update on the All of Us program during the Bio-IT World Conference & Expo this week held in Boston and online.

The All of Us program is the National Institutes of Health’s effort at building one of the most diverse health information databases in history. Genome-wide association studies has thus far had a surprising lack of diversity, Denny said, citing data from several papers giving overviews of GWAS makeup. The authors found that public GWAS studies represent about 78% European ancestry participants. In fact, only 4% of GWAS data are from non-European and non-Asian ancestry donors—a group that represents 1/3 of the US population.

Such nondiverse genetic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Precision Medicine, Trends
Estonian Biobank to Sequence 10,000 Genomes as Part of Precision Medicine Project
Precision Immune Start-Up Mirador Launches with $400M+
The future of companion diagnostic (CDx) development: Why commercialization is key
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs

Share This Article